Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2025-12-24 @ 11:54 PM
NCT ID:
NCT04994951
Eligibility Criteria:
Inclusion Criteria:
* 18-65 years;
* Had a diagnosis of psoriasis vulgaris for ≥6 months;
* TCM syndrome evaluation belongs to blood-heat type patients: it is more common in the advanced stage of psoriasis. Symptoms: skin lesions develop faster, skin lesions are bright red, blood loss is obvious, scales are dry and thick, itching is severe; upset, and thirsty, dry stool; red-purple tongue, yellow fur, string or slippery or rapid pulse;
* Patients without serious primary diseases, such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system or mental illnesses;
* Those who are willing to cooperate and can persist in the treatment without interruption;
* During the treatment period, those who have not taken or used other psoriasis drugs externally.
Exclusion Criteria:
* Patients with serious primary diseases, such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system or mental illnesses;
* History of immunosuppressant medication in the past three months;
* Those who use other drugs during treatment or stop treatment on their own and have incomplete observation data;
* Pregnancy or risk of pregnancy, and/or lactation;
* Aged ≤18 or ≥65 years old;
* Patients with other types of psoriasis, such as articular, pustular, and erythroderma.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT04994951
Study Brief:
Protocol Section:
NCT04994951